KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Astrazeneca (AZN) Non-Current Deferred Tax Liability (2016 - 2025)

Astrazeneca has reported Non-Current Deferred Tax Liability over the past 11 years, most recently at $3.5 billion for Q4 2025.

  • Quarterly results put Non-Current Deferred Tax Liability at $3.5 billion for Q4 2025, up 5.9% from a year ago — trailing twelve months through Dec 2025 was $3.5 billion (up 5.9% YoY), and the annual figure for FY2025 was $3.5 billion, up 5.9%.
  • Non-Current Deferred Tax Liability for Q4 2025 was $3.5 billion at Astrazeneca, up from $3.3 billion in the prior quarter.
  • Over the last five years, Non-Current Deferred Tax Liability for AZN hit a ceiling of $6.2 billion in Q4 2021 and a floor of $2.8 billion in Q4 2023.
  • Median Non-Current Deferred Tax Liability over the past 5 years was $3.3 billion (2024), compared with a mean of $3.8 billion.
  • Biggest five-year swings in Non-Current Deferred Tax Liability: soared 112.68% in 2021 and later plummeted 52.56% in 2022.
  • Astrazeneca's Non-Current Deferred Tax Liability stood at $6.2 billion in 2021, then plummeted by 52.56% to $2.9 billion in 2022, then dropped by 3.4% to $2.8 billion in 2023, then rose by 16.21% to $3.3 billion in 2024, then rose by 5.9% to $3.5 billion in 2025.
  • The last three reported values for Non-Current Deferred Tax Liability were $3.5 billion (Q4 2025), $3.3 billion (Q4 2024), and $2.8 billion (Q4 2023) per Business Quant data.